Exploring melanoma shifts: a two-decade analysis in New Zealand.

Autor:	Wen D; Department of General Surgery, North Shore Hospital, Te Whatu Ora - Health New Zealand Waitematā, New Zealand., Pullman JS; Department of General Surgery, North Shore Hospital, Te Whatu Ora - Health New Zealand Waitematā, New Zealand., Sharma A; Department of General Surgery, North Shore Hospital, Te Whatu Ora - Health New Zealand Waitematā, New Zealand., van der Werf B; Department of Epidemiology and Biostatistics, School of Population Health, Faculty of Medical and Health Sciences, The University of Auckland, New Zealand., Martin RCW
Jazyk:	angličtina
Zdroj:	The New Zealand medical journal [N Z Med J] 2024 Jun 07; Vol. 137 (1596), pp. 35-42. Date of Electronic Publication: 2024 Jun 07.
DOI:	10.26635/6965.6430
Abstrakt:	Aims: New Zealand melanoma incidence rates are amongst the highest in the world. The study aims to provide information on the incidence of cutaneous melanoma in New Zealand from 2000 to 2022. Methods: De-identified data were extracted from the New Zealand Cancer Registry using the ICD-10 code for malignant melanoma (C34) and melanoma in situ (MIS) (D03) from 2000 to 2022. Statistical analysis was performed to calculate melanoma incidence rates. Results: Invasive melanoma (IM) incidence rates demonstrated an increasing trend from 2000 to 2008 (+1.10 per 100,000 person-years per year), followed by an inflection point at 2008 and then a decreasing trend from 2008 to 2022 (-0.28 per 100,000 person-years per year), which was not statistically different from zero/no change. MIS incidence increased from 30.3 to 72.1 per 100,000 person-years between 2000 and 2022. Conclusions: The incidence of IM in New Zealand has plateaued in the last decade and was associated with an increase in MIS incidence over the same period. While this trend is encouraging, further research is required to investigate whether there is an actual decline in IM incidence. Competing Interests: We declare that all authors involved in the preparation and submission of this journal article have no commercial financial incentives related to the publication. We affirm that there are no competing interests that could compromise the integrity, objectivity or impartiality of the research and its reporting. We disclose no conflicts of interest that could potentially bias the findings or conclusions. This study was registered and approved by the Waitematā District Health Board research ethics committee. (© PMA.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu